Lawmakers urge USPTO to curb IPR denials under Fintiv

21-09-2021

Alex Baldwin

Lawmakers urge USPTO to curb IPR denials under Fintiv

markvanscyoc / shutterstock.com

Several US lawmakers have called upon the US Patent and Trademark Office (USPTO) to curb the increase in inter partes review denials to combat the “soaring cost” of prescription drugs.


NHK Fintiv, Fintiv, Apple, Inter Partes Review, Elizabeth Warren, USPTO, Supreme Court, antitrust, generics

LSIPR